Changes to the website
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4919

Previous 25           Next 25
Website Changes
11/26/2016 Society for Neuro Oncology annual meeting, Scottsdale Arizona, November 17-20 2016
11/25/2016 Clinical and Pre-Clinical Data on Mustang Bio’s MB-101 (IL13Ra2-specific CAR T cells) for the Treatment of Glioblastoma (GBM) Presented at the 21st Annual Meeting and Education Day of the Society for Neuro-Oncology
11/25/2016 ZIOPHARM Announces Clinical Data on Ad-RTS-hIL-12 Demonstrates Survival Benefits in Patients with Recurrent Brain Cancer
11/24/2016 Dr. Reardon on the KEYNOTE-028 Trial of Pembrolizumab for GBM
11/23/2016 Help Us Better Understand Glioblastoma Multiforme (GBM) Patient Experiences
11/21/2016 Society of Neuro-Oncology Annual Meeting Abstract Now Available Online!
11/21/2016 ImmunoCellular Therapeutics (IMUC) Announces Presentation of Updated ICT-107 Phase 2 Data in GBM
11/21/2016 Tocagen Presents Updated Clinical and Preclinical Data at Scientific Meetings
11/18/2016 Long-Term Analysis of All 695 Patients Enrolled in Novocure’s Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Confirms Successful Interim Analysis Results and Demonstrates Superior Two- and Four-Year Survival Rates
11/09/2016 DNAtrix Announces First Patients Treated in Phase 2 Trial with DNX-2401 and KEYTRUDA
11/09/2016 Musella Foundation Co-payment Assistance Program is now closed to new patients
11/09/2016 New vaccine for brain cancer brings hope to those fighting the disease
11/08/2016 Posttranslational Regulation of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and New Opportunities for Treatment of Brain Cancers.
11/07/2016 Novocure Announces 38 Presentations on Tumor Treating Fields at 21st Annual Scientific Meeting of the Society of Neuro-Oncology
11/07/2016 United Healthcare Issues Positive Coverage Decision for Optune
10/25/2016 Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature.
10/23/2016 The Musella Foundation announced that it has awarded a $25,000 brain tumor research grant to Dr. Robert Prins of UCLA.
10/22/2016 Patient-Tailored Immunotherapy Shows Promise in Treating Brain Cancer
10/20/2016 An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers.
10/09/2016 High response rate in phase I/II paediatric brain cancer trial
10/09/2016 Exclusive: Interview With DelMar Pharmaceutical CEO Jeffrey Bacha
10/09/2016 Darren Daulton Battling Brain Cancer Through Charitable Foundation
10/09/2016 CIK Treatment Extends Progression-free Survival of Glioblastoma Patients by 1.5 Times
10/09/2016 Last chance for NY Islanders Home Opener Fundraiser!
10/06/2016 Veteran With Terminal Brain Cancer Explains Why He’s Against Assisted Suicide



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites